162 related articles for article (PubMed ID: 32695241)
1. Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma.
Lu LH; Wei-Wei ; Kan A; Jie-Mei ; Ling YH; Li SH; Guo RP
Dis Markers; 2020; 2020():4269460. PubMed ID: 32695241
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy.
Fu S; Guo Z; Li S; Kuang M; Hu W; Hua Y; He X; Peng B
Tumour Biol; 2016 Mar; 37(3):3433-40. PubMed ID: 26449826
[TBL] [Abstract][Full Text] [Related]
3. Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
Fu SJ; Zhao Q; Ji F; Chen MG; Wu LW; Ren QQ; Guo ZY; He XS
Sci Rep; 2016 Jul; 6():28835. PubMed ID: 27381639
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
Sun LY; Cen WJ; Zeng XX; Zhong YY; Deng L; Yang JJ; Li M; Wang F
Am Surg; 2024 Jun; 90(6):1240-1249. PubMed ID: 38214585
[TBL] [Abstract][Full Text] [Related]
5. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Zhang Q; Jiao X
Comput Math Methods Med; 2021; 2021():9809990. PubMed ID: 34845414
[TBL] [Abstract][Full Text] [Related]
6. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
Lin K; Huang Q; Zeng J; Ding Z; Wang L; Chen Z; Guo P; Zeng Y; Zhou W; Liu J
Dig Dis Sci; 2021 Dec; 66(12):4545-4556. PubMed ID: 33723698
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
10. Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation.
Ince V; Carr BI; Bag HG; Koc C; Usta S; Ersan V; Baskiran A; Sahin TT; Yilmaz S
Int J Biol Markers; 2020 Jun; 35(2):91-95. PubMed ID: 32436751
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Lu LH; Zhang YF; Wei W; Shi M; Guo RP
J Gastrointest Surg; 2017 Dec; 21(12):2025-2032. PubMed ID: 28840443
[TBL] [Abstract][Full Text] [Related]
14. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
[TBL] [Abstract][Full Text] [Related]
15. γ-Glutamyltranspeptidase as a Prognostic Biomarker in Advanced Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Guo J; Liu S; Gao S; Kou F; Zhang X; Liu P; Yang R; Zhu X
J Vasc Interv Radiol; 2021 Mar; 32(3):419-428.e2. PubMed ID: 33067120
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
[TBL] [Abstract][Full Text] [Related]
17. High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma.
Song P; Inagaki Y; Wang Z; Hasegawa K; Sakamoto Y; Arita J; Tang W; Kokudo N
Medicine (Baltimore); 2015 May; 94(21):e810. PubMed ID: 26020384
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
An SL; Xiao T; Wang LM; Rong WQ; Wu F; Feng L; Liu FQ; Tian F; Wu JX
Asian Pac J Cancer Prev; 2015; 16(10):4421-7. PubMed ID: 26028108
[TBL] [Abstract][Full Text] [Related]
19. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
20. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
Chon YE; Choi GH; Lee MH; Kim SU; Kim DY; Ahn SH; Kim KS; Choi JS; Han KH; Chon CY; Park JY
Int J Cancer; 2012 Nov; 131(10):2332-41. PubMed ID: 22362471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
